Columbia Technology Ventures

CTV's December newsletter is now live! This special edition shares recommendations for VCs and tech transfer offices on term sheet structuring and process improvements when negotiating life science startup deals. https://mailchi.mp/columbia/columbia-technology-1310592

Over the past 6 months, tech transfer directors from Columbia, Duke, JHU, Penn, MIT, Stanford, and Yale worked with premier life science VCs from 5AM, Atlas, Polaris, OUP, RA Capital, and Venrock to create a common set of principles for university startup deal negotiations. Below link to the resulting set of best practices, meant to benefit universities and VCs more broadly. https://techventures.columbia.edu/recommended-process-impro https://techventures.columbia.edu/term-sheet-recommendation

Innovation through collaboration across Columbia Engineering, Columbia’s Herbert Irving Comprehensive Cancer Center (HICCC), and the Columbia University Irving Medical Center (CUIMC)! https://magazine.engineering.columbia.edu//faculty-qa-join

CTV is seeking an Industry Relations Coordinator! This position will report to the Director of the Columbia Lab-to-Market Accelerator Network and will work closely with CTV’s Executive Director and stakeholders across Columbia schools and departments. Apply here: https://opportunities.columbia.edu/cw/en-us/job/510683

https://www.nytimes.com//life-science-new-york-coronavirus

Osage University Partners gave a great presentation to Columbia PIs on the roles and stakes that founding academic scientists have in startups and how those roles and stakes change over time. Watch on CTV's Vimeo page: https://vimeo.com/481284193

The approach could be used to treat dozens of diseases, including cystic fibrosis, that arise from the destruction of imperfect but still perfectly functional proteins. The article includes a video of Dr. Henry Colecraft presenting at CTV's 2019 VC Pitch Day! https://www.cuimc.columbia.edu//synthetic-llama-antibodies

Deerfield has committed up to $130 million over 10 years to accelerate drug discovery at Columbia. https://globaluniversityventuring.com/does-deerfield-have-/

Apply to the Artificial Intelligence Molecular Screen (AIMS) Awards by Dec. 14! Atomwise will award researchers with a customized virtual screen using cutting-edge AI technology. Details here: https://techventures.columbia.edu/AIMS2020

Columbia's 3D-printed face shields are mentioned at 1:06:10 of the Bayh-Dole 40th Anniversary Celebration! Watch the event here: https://bayhdole40.org/bayh-dole-40th-anniversary-celebrat/

Congratulations, Dean Boyce! https://president.columbia.edu//mary-c-boyce-appointed-pro

The companies selected to participate in the four-month program will receive a $100,000 investment and the potential for follow-on funding from ERA’s Fund. https://www.eranyc.com/apply/

Apply by Nov. 30!

Tomorrow at 9AM EST, CTV will host a conversation with United States Patent and Trademark Office Director and Under Secretary of Commerce Andrei Iancu, who will discuss the role IP plays in innovation and efforts to expand the US innovation ecosystem. Register here: https://usptoatcolumbia.splashthat.com/

The next RFP will open during the Spring semester! https://www.healio.com//nyu-columbia-takeda-partner-for-gi

The Columbia Life Science Accelerators are currently soliciting pre-proposals from Columbia faculty-led teams! To learn more, please join our virtual info session on Monday, October 26 from 2-3PM EST. Register here: https://columbialsavirtualinfosessions.splashthat.com/

Join Columbia Engineering on Dec. 8 for the Urban Works India challenge! Urban Works India is part of the Columbia Venture Competition and $50,000 is at stake. The faculty lead this year is Dr. Mike Massimino, who will discuss the view of cities from space and why it is important to design and support sustainable cities. https://www.eventbrite.com/e/urban-works-india-kickoff-tick

Congrats to Columbia startup Respirogen, winner of the BioNJ Company and Pitch Presentation Competition's Institution Spin-Out Pitch! Respirogen has developed Micro-Oxygen technology that provides systemic oxygen delivery to the body, addressing hypoxia in lung injured patients. https://respirogen.com/

Are you an early-stage team developing innovative solutions in data transparency, big data, AI/ML, blockchain, cybersecurity or related fields in deep tech? Apply now to the 2020-2021 cohort of The Columbia | IBM Launch Accelerator and join an upcoming virtual info session this Thursday, October 22nd from 2-3PM EST. Register here: https://2020launchinfosessions.splashthat.com/

"In this study, we showed how DNA can serve as a scaffold for building 3-D nanoscale architectures that can be fully 'converted' into inorganic materials like superconductors," said Dr. Oleg Gang. https://www.engineering.columbia.edu//gang-3d-nanosupercon

Join us next week for a virtual SBIR/ STTR workshop with BBCetc hosted by the Center for Biotechnology at Stony Brook University in partnership with Columbia Technology Ventures and Silicon Valley Bank. Details here: https://tinyurl.com/y479vfhl

Next week, CTV will host a conversation with United States Patent and Trademark Office Director and Under Secretary of Commerce Andrei Iancu, who will discuss the role IP plays in innovation and efforts to expand the US innovation ecosystem. Details here: https://usptoatcolumbia.splashthat.com/

A great story about Columbia's Dr. Gordana Vunjak-Novakovic engineering a solution to a problem faced by her dentistry colleagues. https://www.nytimes.com//heal/jawbone-stem-cells-pigs.html

The application deadline for the Columbia | IBM Launch Accelerator has been extended to Monday at 5PM. Take advantage of this unique opportunity to receive non-dilutive funding, mentorship from top business and technical mentors, as well as a robust curriculum to help validate your innovative data transparency, big data, AI/ML, cybersecurity, and blockchain applications. Apply here: https://columbiaibmlaunch.submittable.com//2020-2021-colum

Tomorrow is the last day to apply for the Columbia Biomedical Engineering Technology Accelerator (BiomedX), Accelerating Cancer Therapeutics (ACT), and Translational Therapeutics Accelerator (TRx)! Apply here: https://columbialsa.submittable.com/submit

"In the realm of diagnostics, the combination of wearable devices and data analytics is moving from theory to practice; I’m excited that we’re situated right at the intersection of this impending transformation." - Prof. Sam Sia https://www.engineering.columbia.edu//sia-big-idea-microfl

Columbia's Office of Research Compliance and Training is offering a five-part series, "Responsible and Ethical Conduct of Research Training for Postdocs," starting with "Navigating Relationships with Industry" on Oct. 21. The series is open to anyone: https://research.columbia.edu/recr-training-postdocs

Just announced: CTV will host a conversation with United States Patent and Trademark Office Director and Under Secretary of Commerce Andrei Iancu on Dec. 4 at 9AM. Director Iancu will discuss the role IP plays in innovation and efforts to expand the US innovation ecosystem. Register here to download the calendar invite: https://usptoatcolumbia.splashthat.com/

Lilly's collaborators, AbCellera Biologics Inc., Shanghai Junshi Biosciences Co., Ltd. and Columbia University, have agreed to waive their royalties on the Lilly therapeutic antibodies distributed in low- and middle-income countries as part of this initiative. https://investor.lilly.com//lilly-announces-arrangement-su

SummerBio’s COVID-19 test is based on a RT-PCR assay developed by an expert team at Columbia University. Full announcement here: https://static1.squarespace.com//1605664430076/SummerBio+P

NewYorkBIO's interview with CTV's Orin Herskowitz is now on YouTube! Watch it here: https://www.youtube.com/watch?v=nnM5BnXGyj4

November is Pancreatic Cancer Awareness Month. Dr. Kenneth Olive works on finding new strategies for treatment that target aspects of biology needed by pancreatic cancer to survive. https://cancer.columbia.edu/hitting-pancreatic-cancer-where

Tomorrow at 10AM, CTV's Dr. Ofra Weinberger will discuss the key factors needed to attract investors with Thomas Gallagher, Stephen Pitt, Elizabeth Sigety, and Michael Glynn. Register here: https://www.eventbrite.com/e/life-sciences-summit-2020-regi

CTV's Dr. Ofra Weinberger is a speaker in the Life Sciences Summit "Show Me the Money: Preparing Your Company for Funding" panel on Tuesday, 10-10:45AM. Register here: https://lifesciencessummit.org/2020-program-outline/

Congratulations to Dr. Scott Kanner, who just pitched Stablix at the NYC Life Science Innovation Showcase! Stablix is developing novel, orally bioavailable small molecule therapeutics that harness the power of the body’s own cellular machinery to restore protein expression, stability, and function to treat disease.

Congrats to Dr. Tal Danino, who just pitched at the NYC Life Science Innovation Showcase! Dr. Danino presented GenCirq, whose proprietary Synchronized Lysis Circuit technology allows them to engineer tumor-homing bacteria to serve as living bioreactors inside of tumors. https://www.gencirq.com/